Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Michele Hu speaks at the Annual Parkinson's UK Flagship Lecture at the Royal Institution.

On 6 November 2014 Dr Michele Hu from the Nuffield Department of Clinical Neurosciences and Dr Alistair Noyce from UCL gave presentations about the search for biomarkers, stratification and how this could lead to more bespoke treatments for Parkinson’s.

The speakers were joined by the newly appointed Parkinson's UK Director of Research and Innovation, Dr Arthur Roach, for a Q&A session after the talks. Colin Cheesman, a Parkinson's UK trustee, gave closing remarks.

The lecture was attended by around 300 people, largely those affected by Parkinson's but also students and other supporters of the charity. 

Read more about our work on Parkinson's and other movement disorders.

 

“Thank you so much for a fascinating evening yesterday. It was really exciting to hear what kind of projects our fund raising is supporting. All the speakers were excellent and took great trouble to make the talks clear and informative and the final speaker giving a patient's view was very moving.”
- Event attendee

 

 

Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

Celebrating International Women's Day

100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.